1 min read
Add as a preferred source on GoogleCoherus Lowers Quarterly LOQTORZI Revenue Needed for Core Cash Burn
The new range is $25 million to $30 million per quarter. Coherus expects core cash burn to fall by $6 million to $7 million per quarter, with benefits realized over the next two quarters.
Coherus Oncology lowered the quarterly LOQTORZI revenue needed to cover core cash burn to $25 million to $30 million and expects a $6 million to $7 million quarterly decline in core cash burn.
The previous threshold was $30 million to $35 million per quarter.
Coherus expects the benefits to be realized over the next two quarters.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.